Journal Article

Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure

Cocciolo, Andrea, Jones, Kenneth L., Bristow, Michael R., Ambardekar, Amrut V., Sweet, Joseph R., Mestroni, Luisa, Slavov, Dobromir, Graw, Sharon L., Taylor, Matthew R. G., Sweet, Mary E., Reece, T. Brett

2018

Overview

Background Current heart failure (HF) treatment is based on targeting symptoms and left ventricle dysfunction severity, relying on a common HF pathway paradigm to justify common treatments for HF patients. This common strategy may belie an incomplete understanding of heterogeneous underlying mechanisms and could be a barrier to more precise treatments. We hypothesized we could use RNA-sequencing (RNA-seq) in human heart tissue to delineate HF etiology-specific gene expression signatures. Results RNA-seq from 64 human left ventricular samples: 37 dilated (DCM), 13 ischemic (ICM), and 14 non-failing (NF). Using a multi-analytic approach including covariate adjustment for age and sex, differentially expressed genes (DEGs) were identified characterizing HF and disease-specific expression. Pathway analysis investigated enrichment for biologically relevant pathways and functions. DCM vs NF and ICM vs NF had shared HF-DEGs that were enriched for the fetal gene program and mitochondrial dysfunction. DCM-specific DEGs were enriched for cell-cell and cell-matrix adhesion pathways. ICM-specific DEGs were enriched for cytoskeletal and immune pathway activation. Using the ICM and DCM DEG signatures from our data we were able to correctly classify the phenotypes of 24/31 ICM and 32/36 DCM samples from publicly available replication datasets. Conclusions Our results demonstrate the commonality of mitochondrial dysfunction in end-stage HF but more importantly reveal key etiology-specific signatures. Dysfunctional cell-cell and cell-matrix adhesion signatures typified DCM whereas signals related to immune and fibrotic responses were seen in ICM. These findings suggest that transcriptome signatures may distinguish end-stage heart failure, shedding light on underlying biological differences between ICM and DCM.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Adhesion / Animal Genetics and Genomics / Atherosclerosis / Bioinformatics / Biomarkers - analysis / Biomedical and Life Sciences / Cardiomyopathy / Cardiomyopathy, Dilated - genetics / Cardiomyopathy, Dilated - pathology / Case-Control Studies / Cell Adhesion / Cell adhesion & migration / Commonality / Cytoskeleton / Dilated cardiomyopathy / Disease / Enrichment / Etiology / Female / Fetuses / Fibrosis / Gene expression / Gene Expression Profiling - methods / Gene sequencing / Genetic aspects / Genomics / Heart / Heart diseases / Heart failure / Heart Failure - genetics / Heart Failure - pathology / High-Throughput Nucleotide Sequencing - methods / Human and rodent genomics / Humans / Immune response / Immunity, Cellular / Ischemia / Kinases / Life Sciences / Male / Medical prognosis / Microarrays / Microbial Genetics and Genomics / Middle Aged / Mitochondria / Myocardial Ischemia - genetics / Myocardial Ischemia - pathology / Phenotypes / Plant Genetics and Genomics / Principal components analysis / Proteomics / Research Article / Ribonucleic acid / RNA / RNA-seq / Signatures / Transcription (Genetics) / Transcriptome / Ventricle